EMA publishes risk levels of experts based on industry connections
This article was originally published in SRA
Executive Summary
The European Medicines Agency has published the "risk levels" of all the experts that are involved in its drug regulatory activities, based on the interests they have declared in relation to the pharmaceutical industry1. The risk levels are used together with the declarations of interests to determine the extent to which a particular expert can take part in the agency's drug authorisation and surveillance operations.